U6H-28416-16757
3 vaccinations
3 coded responses
32 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 0-4
- ZIP prefix
- 220 / VA
- Registered
- 2022-07-14
- Relationship
- Child or adolescent in my care
- Guardian
- 8AP-11205-39982
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-12
Dose 1 — Pfizer-BioNTech
-
2022-07-14
Registered in v-safe
- 2022-07-14
-
2022-07-15
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Irritability/cryingUnder 3 check-in
- 2022-07-16
- 2022-07-17
- 2022-07-18
- 2022-07-19
- 2022-07-26
- 2022-08-02
-
2022-08-09
Dose 2 — Pfizer-BioNTech
- 2022-08-09
-
2022-08-10
Health check-in — days 1–6 daily, dose 2, under 3Feeling: Fair · Irritability/cryingUnder 3 check-in
- 2022-08-13
- 2022-08-14
- 2022-08-15
- 2022-08-16
- 2022-08-23
-
2022-08-30
Survey response — day 21, dose 2, under 3MedDRA: Cough, Nasopharyngitis — Feeling: FairFree text: Cough and coldMedDRA releases: 2024-11 · check-in free text available
- 2022-09-08
- 2022-09-13
- 2022-09-20
-
2022-10-05
Dose 3 — Pfizer-BioNTech
- 2022-10-07
- 2022-10-08
- 2022-10-09
- 2022-10-10
- 2022-10-11
- 2022-10-12
- 2022-10-20
-
2022-10-26
Survey response — day 21, dose 3, under 3MedDRA: Cough, Ear infection — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Ear infection and coughMedDRA releases: 2024-11 · check-in free text available
-
2022-10-26
Report sent to call center — day 21, dose 3, under 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-10-27
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2022-11-02
- 2022-11-09
-
2022-11-16
Survey response — day 42, dose 3, under 3MedDRA: Respiratory tract infection viral — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Respiratory virusMedDRA releases: 2024-11 · check-in free text available
-
2022-11-16
Report sent to call center — day 42, dose 3, under 3Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
-
2022-11-17
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
- 2023-01-04
- 2023-04-06
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-12 | Pfizer-BioNTech | No |
| 2 | 2022-08-09 | Pfizer-BioNTech | No |
| 3 | 2022-10-05 | Pfizer-BioNTech | No |
Call center
2 call center cases
2 successful
Free text
Release 12 (Under 3) — day 21, dose 2, under 3
Symptoms: Cough and cold
Release 12 (Under 3) — day 21, dose 3, under 3
Symptoms: Ear infection and cough
Release 12 (Under 3) — day 42, dose 3, under 3
Symptoms: Respiratory virus
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Ear infection | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Respiratory tract infection viral | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release